Nifty
:
23850.90
Sensex
:
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)
Nifty
Sensex
:
:
23850.90
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 524494 | NSE: IPCALAB

NSE BSE
1192.75
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1175.05
  •  1198.80
  •  1174.50
  •  1177.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1038443
  •  12377.63
  •  1708.65
  •  971.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 40,389.71
  • 70.03
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 41,480.37
  • 0.25%
  • 6.19

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 46.30%
  • 0.47%
  • 6.93%
  • FII
  • DII
  • Others
  • 10.83%
  • 33.74%
  • 1.73%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.32
  • 10.65
  • 9.75

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.41
  • 7.26
  • 0.10

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.89
  • -2.05
  • -15.12

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.01
  • 32.23
  • 39.11

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.33
  • 4.90
  • 4.39

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.85
  • 20.16
  • 20.77

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
2,092.63
1,585.21
32.01%
2,033.01
1,511.63
34.49%
2,052.86
1,546.00
32.79%
2,033.96
1,600.95
27.05%
Expenses
1,699.91
1,277.39
33.08%
1,711.11
1,330.59
28.60%
1,721.53
1,330.14
29.42%
1,712.69
1,340.31
27.78%
EBITDA
392.72
307.82
27.58%
321.90
181.04
77.81%
331.33
215.86
53.49%
321.27
260.64
23.26%
EBIDTM
18.77%
19.42%
15.83%
11.98%
16.14%
13.96%
15.80%
16.28%
Other Income
20.61
44.85
-54.05%
18.92
36.39
-48.01%
22.45
30.89
-27.32%
38.55
36.23
6.40%
Interest
24.05
31.38
-23.36%
29.37
18.45
59.19%
33.40
10.84
208.12%
44.12
9.31
373.90%
Depreciation
98.89
69.27
42.76%
98.13
69.54
41.11%
99.50
66.57
49.47%
90.34
63.74
41.73%
PBT
290.39
251.82
15.32%
76.60
129.44
-40.82%
288.89
169.34
70.60%
225.36
223.82
0.69%
Tax
91.41
85.61
6.77%
73.69
48.37
52.35%
66.24
53.73
23.28%
87.92
77.00
14.18%
PAT
198.98
166.21
19.72%
2.91
81.07
-96.41%
222.65
115.61
92.59%
137.44
146.82
-6.39%
PATM
9.51%
10.48%
0.14%
5.36%
10.85%
7.48%
6.76%
9.17%
EPS
7.58
6.42
18.07%
2.35
3.02
-22.19%
7.09
4.25
66.82%
5.72
5.67
0.88%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
8,212.46
7,662.43
6,204.26
5,796.74
5,394.94
4,619.03
3,745.69
3,257.76
3,156.19
2,867.11
3,144.40
Net Sales Growth
31.53%
23.50%
7.03%
7.45%
16.80%
23.32%
14.98%
3.22%
10.08%
-8.82%
 
Cost Of Goods Sold
2,703.91
2,251.73
2,079.50
1,790.78
1,547.98
1,455.41
1,090.34
978.34
939.40
903.04
968.00
Gross Profit
5,508.55
5,410.70
4,124.76
4,005.96
3,846.96
3,163.62
2,655.35
2,279.42
2,216.79
1,964.07
2,176.40
GP Margin
67.08%
70.61%
66.48%
69.11%
71.31%
68.49%
70.89%
69.97%
70.24%
68.50%
69.22%
Total Expenditure
6,845.24
6,398.38
5,300.99
4,539.12
3,913.71
3,728.56
3,067.42
2,815.78
2,740.77
2,593.42
2,630.33
Power & Fuel Cost
-
333.97
283.74
242.12
207.10
201.22
176.50
161.92
151.00
141.67
135.94
% Of Sales
-
4.36%
4.57%
4.18%
3.84%
4.36%
4.71%
4.97%
4.78%
4.94%
4.32%
Employee Cost
-
1,708.43
1,287.64
1,177.39
1,013.57
921.23
787.40
735.88
695.98
625.58
566.70
% Of Sales
-
22.30%
20.75%
20.31%
18.79%
19.94%
21.02%
22.59%
22.05%
21.82%
18.02%
Manufacturing Exp.
-
892.99
655.66
610.03
524.21
471.80
374.26
366.92
404.52
387.75
439.11
% Of Sales
-
11.65%
10.57%
10.52%
9.72%
10.21%
9.99%
11.26%
12.82%
13.52%
13.96%
General & Admin Exp.
-
345.05
296.10
261.34
242.22
249.90
271.85
268.52
246.68
245.42
246.73
% Of Sales
-
4.50%
4.77%
4.51%
4.49%
5.41%
7.26%
8.24%
7.82%
8.56%
7.85%
Selling & Distn. Exp.
-
745.87
595.47
402.81
324.86
359.15
317.84
277.62
280.74
223.67
245.00
% Of Sales
-
9.73%
9.60%
6.95%
6.02%
7.78%
8.49%
8.52%
8.89%
7.80%
7.79%
Miscellaneous Exp.
-
120.34
102.88
54.65
53.77
69.85
49.23
26.58
22.45
66.29
245.00
% Of Sales
-
1.57%
1.66%
0.94%
1.00%
1.51%
1.31%
0.82%
0.71%
2.31%
0.92%
EBITDA
1,367.22
1,264.05
903.27
1,257.62
1,481.23
890.47
678.27
441.98
415.42
273.69
514.07
EBITDA Margin
16.65%
16.50%
14.56%
21.70%
27.46%
19.28%
18.11%
13.57%
13.16%
9.55%
16.35%
Other Income
100.53
184.36
151.77
121.72
129.19
86.50
74.66
58.08
54.76
40.77
58.69
Interest
130.94
140.75
48.19
11.20
12.27
19.77
22.24
27.57
26.91
34.56
32.13
Depreciation
386.86
357.24
261.56
232.42
209.17
210.50
182.42
177.73
172.95
163.26
179.55
PBT
881.24
950.42
745.29
1,135.72
1,388.98
746.70
548.27
294.76
270.32
116.64
361.08
Tax
319.26
313.46
253.36
224.77
240.14
135.33
104.24
51.11
67.52
20.44
101.93
Tax Rate
36.23%
37.20%
33.99%
19.79%
17.29%
18.12%
19.01%
17.34%
24.98%
17.52%
28.23%
PAT
561.98
553.64
484.26
905.24
1,147.71
614.13
447.39
243.65
202.80
96.20
259.15
PAT before Minority Interest
580.79
529.21
491.93
910.95
1,148.84
611.37
444.03
243.65
202.80
96.20
259.15
Minority Interest
18.81
24.43
-7.67
-5.71
-1.13
2.76
3.36
0.00
0.00
0.00
0.00
PAT Margin
6.84%
7.23%
7.81%
15.62%
21.27%
13.30%
11.94%
7.48%
6.43%
3.36%
8.24%
PAT Growth
10.25%
14.33%
-46.50%
-21.13%
86.88%
37.27%
83.62%
20.14%
110.81%
-62.88%
 
EPS
22.15
21.82
19.09
35.68
45.24
24.21
17.63
9.60
7.99
3.79
10.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
6,332.19
5,842.02
5,464.84
4,701.65
3,627.48
3,122.39
2,688.57
2,455.26
2,259.19
2,208.43
Share Capital
25.37
25.37
25.37
25.37
25.27
25.27
25.24
25.24
25.24
25.24
Total Reserves
6,305.21
5,816.65
5,439.47
4,676.28
3,590.27
3,097.12
2,663.01
2,430.02
2,233.95
2,183.19
Non-Current Liabilities
1,014.41
901.72
613.87
189.69
290.29
313.40
419.42
548.32
662.57
699.57
Secured Loans
580.41
651.78
395.18
9.13
88.80
133.94
234.01
347.22
433.63
447.65
Unsecured Loans
0.00
0.00
0.00
0.00
14.17
6.91
0.00
4.52
50.64
55.56
Long Term Provisions
86.84
46.99
42.73
38.56
32.23
25.28
25.88
24.55
20.22
18.03
Current Liabilities
2,355.64
1,805.82
1,465.88
1,160.54
1,326.42
1,097.50
1,007.57
955.93
969.95
904.36
Trade Payables
776.08
525.06
557.70
664.86
609.85
524.32
423.47
396.54
421.11
306.59
Other Current Liabilities
732.62
488.15
420.52
204.49
304.57
274.74
266.75
316.41
297.50
236.44
Short Term Borrowings
559.24
661.82
367.81
176.61
310.95
209.69
239.04
177.30
184.85
325.35
Short Term Provisions
287.70
130.79
119.85
114.58
101.05
88.75
78.31
65.68
66.49
35.98
Total Liabilities
11,097.05
8,622.86
7,621.51
6,066.41
5,257.82
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36
Net Block
4,553.53
2,751.38
2,402.19
2,072.43
2,058.73
1,940.38
1,952.96
1,983.27
2,014.18
1,800.43
Gross Block
7,020.79
4,353.42
3,749.46
3,201.39
2,985.73
2,632.86
2,464.33
2,318.22
2,176.95
2,546.33
Accumulated Depreciation
2,467.26
1,602.04
1,331.43
1,128.96
927.00
692.48
511.37
334.95
162.77
745.90
Non Current Assets
5,558.15
3,433.59
3,164.34
2,629.45
2,402.11
2,171.08
2,170.08
2,217.69
2,269.79
2,198.38
Capital Work in Progress
342.89
140.43
306.43
234.82
133.28
66.33
73.00
94.64
128.74
267.22
Non Current Investment
303.61
302.66
269.88
111.43
71.31
30.05
17.52
22.24
25.82
16.19
Long Term Loans & Adv.
315.59
229.61
169.63
184.42
124.68
128.36
115.83
103.58
78.44
103.47
Other Non Current Assets
42.53
9.51
16.21
26.35
14.11
5.96
10.77
13.96
22.61
11.07
Current Assets
5,535.55
5,189.27
4,457.17
3,436.96
2,855.71
2,377.75
1,945.48
1,741.82
1,621.92
1,613.98
Current Investments
558.40
323.32
719.31
393.83
238.25
90.38
69.35
113.57
0.00
0.00
Inventories
2,471.31
1,743.37
1,857.97
1,594.81
1,323.12
1,072.50
880.59
882.22
837.42
926.56
Sundry Debtors
1,686.51
989.02
910.78
811.75
895.20
681.51
602.27
500.16
445.87
353.00
Cash & Bank
296.84
1,853.24
640.66
365.07
180.92
282.30
150.57
35.85
175.54
124.79
Other Current Assets
522.49
124.70
126.65
234.70
218.22
251.06
242.70
210.02
163.09
209.63
Short Term Loans & Adv.
197.48
155.62
201.80
36.80
22.30
29.85
14.44
15.56
17.31
36.19
Net Current Assets
3,179.91
3,383.45
2,991.29
2,276.42
1,529.29
1,280.25
937.91
785.89
651.97
709.62
Total Assets
11,093.70
8,622.86
7,621.51
6,066.41
5,257.82
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
944.65
805.81
856.07
1,090.13
570.35
501.03
341.13
281.91
708.65
455.29
PBT
842.67
745.29
1,135.72
1,388.98
738.89
546.46
290.53
262.06
116.64
361.08
Adjustment
489.87
235.18
195.11
183.07
247.37
187.36
192.51
174.86
211.11
187.91
Changes in Working Capital
-91.59
48.99
-272.72
-236.33
-263.69
-121.97
-84.44
-103.73
410.30
-18.68
Cash after chg. in Working capital
1,240.95
1,029.46
1,058.11
1,335.72
722.57
611.85
398.60
333.19
738.05
530.31
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-296.30
-223.65
-202.04
-245.59
-152.22
-110.82
-57.47
-51.28
-29.40
-75.02
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,291.79
-725.00
-855.05
-520.69
-509.65
-165.06
-135.40
-148.82
-218.33
-676.40
Net Fixed Assets
-337.88
-335.30
-597.37
-307.20
-284.34
-46.98
-60.09
-105.61
466.60
-716.66
Net Investments
-1,597.43
281.97
-470.86
-219.12
-326.48
-106.61
-4.05
-114.15
-15.57
-52.96
Others
643.52
-671.67
213.18
5.63
101.17
-11.47
-71.26
70.94
-669.36
93.22
Cash from Financing Activity
-552.55
507.24
426.78
-305.82
-136.54
-183.20
-130.41
-159.13
-461.51
250.54
Net Cash Inflow / Outflow
-899.69
588.05
427.80
263.62
-75.84
152.77
75.32
-26.04
28.81
29.43
Opening Cash & Equivalents
1,578.98
990.93
559.01
295.39
370.92
218.15
142.83
168.87
140.06
74.25
Closing Cash & Equivalent
755.79
1,578.98
990.93
559.01
295.39
370.92
218.15
142.83
168.87
103.68

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
249.53
230.27
215.41
185.32
286.15
247.12
213.02
194.55
179.02
174.99
ROA
5.37%
6.06%
13.31%
20.29%
12.47%
10.25%
6.03%
5.17%
2.50%
7.38%
ROE
8.70%
8.70%
17.92%
27.63%
18.15%
15.28%
9.47%
8.60%
4.31%
12.43%
ROCE
13.10%
11.71%
20.46%
30.92%
19.92%
16.53%
9.94%
9.44%
4.82%
13.78%
Fixed Asset Turnover
1.35
1.54
1.68
1.75
1.65
1.48
1.37
1.43
1.23
1.42
Receivable days
63.37
55.52
53.92
57.48
61.90
62.09
61.27
53.75
50.16
46.12
Inventory Days
99.83
105.25
108.09
98.25
94.05
94.47
97.98
97.70
110.76
101.93
Payable days
100.50
86.04
111.16
136.39
49.85
51.13
50.35
52.23
52.92
39.11
Cash Conversion Cycle
62.70
74.74
50.86
19.34
106.10
105.43
108.90
99.22
108.00
108.95
Total Debt/Equity
0.22
0.25
0.14
0.05
0.13
0.15
0.23
0.29
0.38
0.42
Interest Cover
6.99
16.47
102.40
114.20
38.77
25.65
11.69
11.05
4.38
12.24

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Ipca Laboratories launches Diulcus
    17th Aug 2024, 11:57 AM

    The product has received approval from the Central Drugs Standard Control Organization

    Read More
  • Ipca Laboratories - Quarterly Results
    13th Aug 2024, 13:13 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.